Notably, our study identified a novel circRNA that prevented PCa cells from DNA damage by preventing PARP1 from caspase‐3‐dependent cleavage, which may be the hopeful therapeutic target for PCa. The gene discussed is PARP1; the disease is posterior cortical atrophy.